Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Published 28/03/2024, 06:36
Updated 28/03/2024, 07:40
© Reuters. Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is expected to release earnings results for its second quarter, before the opening bell on March 28, 2024.

Analysts expect the Deerfield, Illinois-based company to report quarterly earnings at 82 cents per share, down from $1.16 per share in the year-ago period. Walgreens is projected to report quarterly revenue of $35.86 billion, according to data from Benzinga Pro.

Walgreens has reportedly taken legal action against an arbitration award of nearly $1 billion issued to telemedicine provider PWNHealth in a contract dispute.

Walgreens shares gained 2.5% to close at $21.02 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Morgan Stanley analyst Erin Wright maintained an Underweight rating and cut the price target from $22 to $21 on March 26, 2024. This analyst has an accuracy rate of 77%.
  • RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and cut the price target from $29 to $26 on Oct. 13, 2023. This analyst has an accuracy rate of 68%.
  • Truist Securities analyst David Macdonald maintained a Hold rating and cut the price target from $30 to $25 on Oct. 11, 2023. This analyst has an accuracy rate of 73%.
  • Mizuho analyst Ann Hynes maintained a Neutral rating and slashed the price target from $31 to $25 on Oct. 10, 2023. This analyst has an accuracy rate of 76%.
  • Deutsche Bank George Hill maintained a Hold rating and lowered the price target from $34 to $27 on Sept. 22, 2023. This analyst has an accuracy rate of 60%.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read This Next: Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'

Latest Ratings for WBA

Dec 2021UBSMaintainsNeutral
Dec 2021Morgan StanleyDowngradesEqual-WeightUnderweight
Dec 2021Morgan StanleyDowngradesEqual-WeightUnderweight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.